Safety Surveillance Research Unit LeadPfizer Inc., United States
Disclosure information not submitted.
1D-05 - Rapid Surveillance Study to Evaluate Safety of Respiratory Syncytial Virus (RSV) Vaccine (ABRYSVO™) Exposure During Pregnancy in the United States
Sunday, August 24, 202511:30 AM - 11:45 AM ET
5C-06 - Incidence Rates of Myocarditis/Pericarditis after Pfizer-BioNTech COVID-19 Vaccine in the United States: Interim Results From a Postapproval Safety Study, Primary Series Analysis
Tuesday, August 26, 20259:45 AM - 10:00 AM ET
